摘要
目的探讨糖化血红蛋白在妊娠期糖尿病诊断中的价值。方法60例妊娠期糖尿病患者纳入研究组,另将60例同期行产检的健康妊娠者纳入对照组,检测两组糖化血红蛋白水平,比较两组检测结果及妊娠结局。结果研究组糖化血红蛋白(8.35±1.23)%、空腹血糖水平(11.58±2.35)mmol/L及服药2 h后血糖水平(8.35±4.12)mmol/L高于对照组的(5.13±0.19)%、(5.02±1.08)mmol/L、(5.03±1.02)mmol/L,差异具有统计学意义(P<0.05)。研究组不良妊娠结局总发生率28.33%(17/60)高于对照组的6.67%(4/60),差异具有统计学意义(P<0.05)。结论针对妊娠期糖尿病患者,对其进行糖化血红蛋白检验能准确判断疾病,可行性高,为疾病的早期筛查、诊断及预后提供有价值的参考及数据支持。
Objective To discuss the value of glycosylated hemoglobin in the diagnosis of gestational diabetes.Methods There were 60 cases of gestational diabetes as research group,and another 60 healthy pregnant women undergoing prenatal examination at the same time were included in the control group.The levels of glycosylated hemoglobin in the two groups were tested,and the test results and pregnancy outcomes of the two groups were compared.Results The glycosylated hemoglobin(8.35±1.23)%,fasting blood glucose(11.58±2.35)mmol/L and blood glucose level 2 h after administration(8.35±4.12)mmol/L of the research group were higher than(5.13±0.19)%,(5.02±1.08)mmol/L and(5.03±1.02)mmol/L of the control group,and the difference was statistically significant(P<0.05).The incidence of adverse pregnancy outcomes 28.33%(17/60)of the research group was higher than 6.67%(4/60)of the control group,and the difference was statistically significant(P<0.05).Conclusion For patients with gestational diabetes,the glycosylated hemoglobin test can accurately determine the disease and is highly feasible,which can provide valuable reference and data support for the early screening,diagnosis and prognosis of the disease.
作者
祝晓静
ZHU Xiaojing(Tengzhou Maternal and Child Health Hospital,Tengzhou 277500,China)
出处
《中国实用医药》
2020年第28期38-40,共3页
China Practical Medicine
关键词
糖化血红蛋白
妊娠期糖尿病
诊断
Glycosylated hemoglobin
Gestational diabetes
Diagnosis
